BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23872737)

  • 1. Biologic markers of chronic GVHD.
    Pidala J; Sarwal M; Roedder S; Lee SJ
    Bone Marrow Transplant; 2014 Mar; 49(3):324-31. PubMed ID: 23872737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD.
    Nagasawa M; Mitsuiki N; Yanagimachi M; Yamamoto M; Fukuda T; Miura O; Oba R; Igarashi A; Nagata K; Morio T
    Int J Hematol; 2021 Jun; 113(6):910-920. PubMed ID: 33683652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
    Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
    Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD.
    Sawamukai N; Satake A; Schmidt AM; Lamborn IT; Ojha P; Tanaka Y; Kambayashi T
    Blood; 2012 Jun; 119(23):5575-83. PubMed ID: 22496155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Gonin R; Murray C; Robertson MJ; Cochran K; Chartier S; Cameron C; Daley J; Levine H; Nadler LM
    Blood; 1993 Oct; 82(7):2216-23. PubMed ID: 7691252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Notch signaling pathway disturbs the CD4
    Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
    Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients.
    Galati D; De Martino M; Trotta A; Rea G; Bruzzese D; Cicchitto G; Stanziola AA; Napolitano M; Sanduzzi A; Bocchino M
    Cytokine; 2014 Apr; 66(2):119-26. PubMed ID: 24418172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.
    Zhang C; Lou J; Li N; Todorov I; Lin CL; Cao YA; Contag CH; Kandeel F; Forman S; Zeng D
    J Immunol; 2007 Jan; 178(2):838-50. PubMed ID: 17202345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.
    Dutt S; Baker J; Kohrt HE; Kambham N; Sanyal M; Negrin RS; Strober S
    Blood; 2011 Mar; 117(11):3230-9. PubMed ID: 21239702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism.
    Leveson-Gower DB; Olson JA; Sega EI; Luong RH; Baker J; Zeiser R; Negrin RS
    Blood; 2011 Mar; 117(11):3220-9. PubMed ID: 21258007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
    Ball JA; Clear A; Aries J; Charrot S; Besley C; Mee M; Stagg A; Lindsay JO; Cavenagh J; Calaminci M; Gribben JG; Davies J
    Blood; 2021 Feb; 137(5):702-717. PubMed ID: 32905596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface markers and circulating cytokines in graft versus host disease.
    Chang DM; Wang CJ; Kuo SY; Lai JH
    Immunol Invest; 1999 Jan; 28(1):77-86. PubMed ID: 10073684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
    Mutis T; Aarts-Riemens T; Verdonck LF
    Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.
    Shah NN; Baird K; Delbrook CP; Fleisher TA; Kohler ME; Rampertaap S; Lemberg K; Hurley CK; Kleiner DE; Merchant MS; Pittaluga S; Sabatino M; Stroncek DF; Wayne AS; Zhang H; Fry TJ; Mackall CL
    Blood; 2015 Jan; 125(5):784-92. PubMed ID: 25452614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.